Call Us for More Information
800.615.2270

Recruiting Clinical Trials

Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: February 22, 2012

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

  • Conditions: Pleural Mesothelioma, Peritoneal Mesothelioma
  • Status: Recruiting
  • Last Updated: March 14, 2012

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

  • Conditions: Mesothelioma, Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: March 8, 2010

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: March 23, 2012

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

  • Conditions: Recurrent Malignant Mesothelioma, Stage IA Malignant Mesothelioma, Stage IB Malignant Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma
  • Status: Recruiting
  • Last Updated: January 25, 2012

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: March 28, 2012

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: May 22, 2008

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers

  • Conditions: Lung Cancer, Mesothelioma
  • Status: Recruiting
  • Last Updated: January 19, 2012

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Recruiting
  • Last Updated: December 6, 2011

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

  • Conditions: Malignant (Pleural) Mesothelioma
  • Status: Recruiting
  • Last Updated: June 22, 2011

Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

  • Conditions: Malignant Mesothelioma
  • Status: Recruiting
  • Last Updated: April 6, 2011

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

  • Conditions: Malignant Mesothelioma, Metastatic Cancer
  • Status: Recruiting
  • Last Updated: December 13, 2009

Axitinib in Malignant Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: September 28, 2010

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: July 20, 2011

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

  • Conditions: Advanced Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: December 30, 2011

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

  • Conditions: Malignant Mesothelioma, Pulmonary Complications
  • Status: Recruiting
  • Last Updated: May 22, 2009

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

  • Conditions: Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Thymoma, Thymic Carcinoma
  • Status: Recruiting
  • Last Updated: April 10, 2012

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: October 28, 2011

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: January 24, 2012

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: April 11, 2012

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

  • Conditions: Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: October 28, 2011

Trimodality Therapy for Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: April 26, 2011

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: December 30, 2011

Combination Gene Transfer and Chemotherapy

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: February 7, 2012

Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: January 21, 2011

Intrapleural Gene Transfer for Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: September 29, 2010

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

  • Conditions: Mesothelioma
  • Status: Recruiting
  • Last Updated: March 22, 2012

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)

  • Conditions: Lung Cancer, Mesothelioma
  • Status: Recruiting
  • Last Updated: January 26, 2012

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

  • Conditions: Soft Tissue Sarcoma, Mesothelioma
  • Status: Recruiting
  • Last Updated: October 28, 2011

Short Neoadjuvant Hemithoracic IMRT for MPM

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: February 11, 2011

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

  • Conditions: Pleural Mesothelioma, Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: October 30, 2009

N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy

  • Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung, Mesothelioma
  • Status: Recruiting
  • Last Updated: August 8, 2011

Autologous Redirected RNA Meso-CIR T Cells

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: May 18, 2011

ChemoFx® PRO - A Post-Market Data Collection Study

  • Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer, Lung Cancer, Carcinoid Tumor of Lung, Sarcoma of Lung, Mesothelioma, Colorectal Cancer
  • Status: Recruiting
  • Last Updated: June 1, 2011

Amatuximab for High Mesothelin Cancers

  • Conditions: Carcinoma, Pancreatic Ductal, Mesothelioma, Ovarian Neoplasms, Carcinoma, Non-Small-Cell Lung
  • Status: Recruiting
  • Last Updated: March 14, 2012

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

  • Conditions: Carcinoma, Small Cell, Carcinoma, Non-small-cell Lung, Esophageal Neoplasms, Mesothelioma
  • Status: Recruiting
  • Last Updated: March 14, 2012

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

  • Conditions: Thoracic Malignancy, Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma
  • Status: Recruiting
  • Last Updated: March 14, 2012

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

  • Conditions: Mesothelioma, Pancreatic Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
  • Status: Recruiting
  • Last Updated: January 27, 2012

Dendritic Cell Vaccination for Patients With Solid Tumors

  • Conditions: Glioblastoma, Renal Cell Carcinoma, Sarcomas, Breast Cancers, Malignant Mesothelioma, Colorectal Tumors
  • Status: Enrolling by invitation
  • Last Updated: February 7, 2011

Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Advanced Lung and Non-colorectal Gastrointestinal Malignancies

  • Conditions: Non-small Cell Lung Cancer, Small Cell Lung Cancer, Mesothelioma, Esophageal Cancer, Gastric Cancer, Liver Cancer, Biliary Cancer
  • Status: Recruiting
  • Last Updated: July 22, 2011

Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis

  • Conditions: Stomach Neoplasms, Colorectal Neoplasms, Neoplasm Metastasis, Mesothelioma
  • Status: Recruiting
  • Last Updated: February 12, 2009

Molecular Analysis of Thoracic Malignancies

  • Conditions: Thymus Cancer, Thymoma, Thymic Carcinoma, Lung Cancer, Carcinoma, Non-Small-Cell Lung, Mesothelioma
  • Status: Recruiting
  • Last Updated: September 23, 2011

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

  • Conditions: Lung Cancer, Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Mesothelioma
  • Status: Recruiting
  • Last Updated: January 18, 2012

Treating Cancer With Anti-mesothelin Modified Lymphocytes

  • Conditions: Metastatic Cancer, Pancreatic Cancer, Mesothelioma
  • Status: Recruiting
  • Last Updated: April 20, 2012

Study of ABT-700 in Subjects With Advanced Solid Tumors

  • Conditions: Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer).
  • Status: Recruiting
  • Last Updated: April 17, 2012

A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

  • Conditions: Solid Organ Tumors
  • Status: Recruiting
  • Last Updated: January 10, 2012

A Study in Non Small Cell Lung Cancer

  • Conditions: Non Small Cell Lung Cancer
  • Status: Recruiting
  • Last Updated: February 10, 2012

Collecting Tumor Samples From Patients With Gynecological Tumors

  • Conditions: Cancer
  • Status: Recruiting
  • Last Updated: December 3, 2011
mesothelioma-packet
Name:
Address:
City, State, Zip:
Country:
Phone Number:
Email:
Diagnosis:
Comments:
terms of use